Efficacy of plasma injections, and extracorporeal shock wave therapy, in thetreatment of work –related lateral epicondylitis
- Conditions
- The epicondylitis is an overuse injury, in most cases, is a self-limited course andresponds well to conservative treatment. Its etiology is degenerative and is relatedto a repetitive overuse and underlying tendinopathy.Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- Registration Number
- EUCTR2018-002650-67-ES
- Lead Sponsor
- Ibermutuamur (Mutua Colaboradora con la Seguridad Social nº 274)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 66
- Workers diagnosed with work-related epicondylitis (ICD 9-CM code 726.32) as the primary diagnosis, receiving healthcare in Ibermutuamur. - Age equal or greater than 18 years. - Patients receive this diagnosis after being explored: painful sensitivity to pressure on the epicondyle; Cozen maneuver; chair test; and
radiological examination. - Does not present remission of symptoms after a period of approximately 25 days of conservative treatment that include oral medication, local cold, functional relative rest and rehabilitation.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 66
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
- Patients with cervical pathology. - With posterior interosseous neuropathy. - With any kind (unless cancer pathology hospital discharge) cancer. - Patients with mental health problems that prevent them from successfully follow rehabilitation treatment. - Patients with thrombocytopenia. - Patients who have pacemakers. - Clotting problems or anticoagulant therapy. - Rheumatoid arthritis diagnosed. - Pregnant or breast-feeding patients. - Treatment with deposit costicoesteroid infiltrations in the last 6 weeks
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method